ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1022

Single Cell Transcriptome Analysis of Circulating Plasmacytoid Dendritic Cells and Switched Memory B-cells in SLE Patients Reveals Transcriptional Subsets Within the Classical Cell Lineages

Amrutesh Puranik1, Yogita Ghodke-Puranik 2, Regine Tipon 2, Mark Jensen 1, Auroni Gupta 3, Jacqueline Paredes 3, Uma Sankaramanchi 4, Ilona Nln 3, Amit Saxena 5, H. Michael Belmont 6, Peter Izmirly 7, Robert Clancy 7, Jill Buyon 5 and Timothy Niewold 2, 1Colton Center for Autoimmunity, NYU School of Medicine, New York, NY, 2Colton Center for Autoimmunity, NYU School of Medicine, New York, 3Colton Center for Autoimmunity, NYU School of Medicine, ny, 4Colton Center for Autoimmunity, NYU Langone Medical Center, NY, 5New York University School of Medicine, New York, NY, 6New York University School of Medicine, Ney York, 7New York University School of Medicine, New York

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Lupus, plasmacytoid dendritic cells and Type I IFN, scRNAseq, switched memory B-cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Both plasmacytoid dendritic cells (pDCs) and switched memory B cells (SMBCs) are considered to be key effector cells in systemic lupus erythematosus.  It seems likely that within these classical cell lineages, additional diversity of function will exist that will contribute to disease pathogenesis.  To explore this question, we performed single-cell RNA sequencing in pDCs and SMBCs from SLE patients and controls to assess gene expression patterns and cellular sub-groupings within these lineages.

Methods: pDCs and SMBCs from SLE patients (n=10) and Healthy controls (n=5) were purified by magnetic separation. For deep sequencing, we used the Fluidigm C1 HT system with 800 capture site chips to capture single cells.  Single cell capture was verified by direct visualization using the Array Scan system, allowing us to remove empty wells and wells with multiple cells.  After quality control and adaptor trimming, the data was analyzed using SeqGeq software. pDCs and SMBCs were clustered using UMAP and pseudo-time analysis was performed using the Monocle program.  Type I IFN activity in SLE plasma was measured using reporter cell assay.

Results: A total of 2774 pDCs and 2578 SMBCs from SLE and healthy controls passed the quality control and were used for further analysis.  In pDCs, we observed unique clusters for patients with high interferon, low interferon, and controls, indicating that the IFN response is a major determinant of overall gene expression patterns in SLE patient pDCs.  IFN signature in pDCs correlated with circulating type I IFN activity in the SLE patients measured at the same time.   Other genes upregulated in pDCs included the type I interferon regulator AXL and MACC1.  The SMBCs were heterogeneous in patients and controls, and in contrast to the pDCs, the overall clustering pattern was independent of the IFN score. SMBC clusters were predominantly defined by genes indicating cellular activation or proliferation such as HLA-DRs and CREB1, or genes associated with nucleic acid processing such as DNASE1 and SNORD3B-1.

Conclusion: We find distinct clusters of cells defined transcriptionally within the pDC and SMBC lineages, and the transcripts which define these subgroups differ between cell lineages.  Type I IFN induced transcripts are important to pDC diversity, while in SMBCs transcripts related to cellular activation and nucleic acid processing are critical markers of transcriptional heterogeneity.


Disclosure: A. Puranik, None; Y. Ghodke-Puranik, None; R. Tipon, None; M. Jensen, None; A. Gupta, None; J. Paredes, None; U. Sankaramanchi, None; I. Nln, None; A. Saxena, Exagen, 2; H. Belmont, None; P. Izmirly, Glaxosmithkline, 5, GSK, 5; R. Clancy, None; J. Buyon, Bristol Myers Squibb, 5, Exagen Diagnostics, 2; T. Niewold, None.

To cite this abstract in AMA style:

Puranik A, Ghodke-Puranik Y, Tipon R, Jensen M, Gupta A, Paredes J, Sankaramanchi U, Nln I, Saxena A, Belmont H, Izmirly P, Clancy R, Buyon J, Niewold T. Single Cell Transcriptome Analysis of Circulating Plasmacytoid Dendritic Cells and Switched Memory B-cells in SLE Patients Reveals Transcriptional Subsets Within the Classical Cell Lineages [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/single-cell-transcriptome-analysis-of-circulating-plasmacytoid-dendritic-cells-and-switched-memory-b-cells-in-sle-patients-reveals-transcriptional-subsets-within-the-classical-cell-lineages/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-transcriptome-analysis-of-circulating-plasmacytoid-dendritic-cells-and-switched-memory-b-cells-in-sle-patients-reveals-transcriptional-subsets-within-the-classical-cell-lineages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology